Table 2.
Nominally significant case–control association test results: OA-JIA sample
| Chr | Position | dbSNP ID | Alleles | Gene (region) | MAF | P | OR | 95% CI | |
|---|---|---|---|---|---|---|---|---|---|
| (Ref/Alt) | |||||||||
| Cases | Controls | ||||||||
| 1 | 62,090,537 | rs1436238830 | T/A | NFIA | 0,478 | 0,377 | 5,05 × 10−6 | 0,661 | 0,540–0,809 |
| 1 | 117,884,022 | rs11586858 | G/A | VTCN1 | 0,178 | 0,256 | 5,80 × 10−5 | 1,590 | 1,222–2,067 |
| 2 | 33,218,037 | rs219158 | A/G | LTBP1 | 0,528 | 0,413 | 9,95 × 10−6 | 1,591 | 1,300–1,947 |
| 3 | 112,484,400 | rs62263666 | T/C | CD200R1 | 0,265 | 0,347 | 2,59 × 10−5 | 0,677 | 0,539–0,850 |
| 7 | 37,157,641 | rs2111035 | C/A | ELMO1 | 0,247 | 0,160 | 9,37 × 10−5 | 1,723 | 1,362–2,179 |
| 10 | 61,620,478 | rs141412077 | A/G | UBE2D1 | 0,076 | 0,034 | 1,45 × 10−5 | 2,357 | 1,600–3,473 |
| 13 | 81,150,170 | rs2154130 | C/T | SPRY2 | 0,322 | 0,433 | 6,18 × 10−5 | 1,605 | 1,294–1,991 |
| 16 | 11,563,226 | rs11074991 | C/A | CLEC16A | 0,204 | 0,292 | 6,03 × 10−5 | 0,620 | 0,483–0,796 |
| 19 | 6,785,961 | rs808843 | G/A | VAV1 | 0,159 | 0,103 | 2,75 × 10−5 | 1,637 | 1,240–2,160 |
| 21 | 42,816,368 | rs28449257 | C/G | MX1 | 0,250 | 0,324 | 1,65 × 10−5 | 0,696 | 0,551–0,878 |
Chr chromosome; MAF minor allele frequency; OR odds ratio; CI confidence intervals